跳至主要内容
临床试验/IRCT20120215009014N354
IRCT20120215009014N354已完成2 期

Evaluating the effect of intravenous hydrocortisone, methylprednisolone, and dexamethasone in treatment of patients with moderate to severe acute respiratory distress syndrome caused by COVID-19: A double blind randomized clinical trial

Hamedan University of Medical Sciences0 个研究点目标入组 81 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
81

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Age of 18 to 70 years,
  • Hospitalized in intensive care unit in less than past 48 hours,
  • Mild to moderate acute respiratory distress syndrome due to COVID-19,
  • Bilateral pulmonary infiltration in chest X-ray or CT-scan,
  • Respiratory distress with more than 24 breathe per minute

排除标准

  • Pregnancy or breastfeeding,
  • Cardiopulmonary edema,
  • Severe acute respiratory distress syndrome,
  • Using antioxidant drugs,
  • Chronic liver or renal disease,
  • Contraindication of N-acetyl cysteine

研究者

相似试验